NPI: 1194799544 · DELANO, CA 93215 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIR LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| DVA RENAL HEALTHCARE INC | SELLS | AZ | $7.17M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 50,009 | $3.03M |
| 2019 | 33,662 | $1.92M |
| 2020 | 28,206 | $2.03M |
| 2021 | 31,087 | $2.31M |
| 2022 | 26,851 | $2.36M |
| 2023 | 19,940 | $2.50M |
| 2024 | 16,064 | $2.29M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 87,788 | 6,614 | $16.24M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 48,952 | 2,638 | $105K |
| J1756 | Injection, iron sucrose, 1 mg | 14,994 | 3,777 | $31K |
| A4657 | Syringe, with or without needle, each | 6,152 | 2,486 | $20K |
| J1270 | Injection, doxercalciferol, 1 mcg | 32,684 | 2,807 | $18K |
| 90674 | 200 | 177 | $5K | |
| 83970 | 2,020 | 1,680 | $3K | |
| 90662 | 50 | 48 | $3K | |
| 82728 | 2,038 | 1,622 | $898.46 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 163 | 127 | $674.53 |
| 83550 | 1,649 | 1,230 | $536.84 | |
| 83540 | 2,033 | 1,596 | $397.92 | |
| 82108 | 739 | 633 | $391.17 | |
| G0008 | Administration of influenza virus vaccine | 104 | 92 | $360.22 |
| 85041 | 2,282 | 2,009 | $181.91 | |
| 85048 | 2,273 | 1,999 | $144.01 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,669 | 963 | $0.00 |
| 85045 | 29 | 26 | $0.00 |